Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
B1101 vs alteplase for acute ischemic stroke (0–4.5 h window)
CTR20180622Phase 3Completed
- Sponsor
- Tasly Pharmaceutical Group Co., Ltd.
- Start
- May 2018
- Modality
- Metabolic Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of recombinant human prourokinase in ischemic stroke, sponsored by Tasly Pharmaceutical Group Co., Ltd.. Started May 2018; status: completed.
02
Drugs
recombinant human prourokinase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on CTR20180622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180622.